scholarly article | Q13442814 |
P50 | author | Cornelia C. Bergmann | Q55426323 |
Richard M Ransohoff | Q87833085 | ||
Timothy W Phares | Q117769739 | ||
Stephen A Stohlman | Q117769757 | ||
P2093 | author name string | Stephen L Nutt | |
David R Hinton | |||
Claudia Hindinger | |||
Cristina P Marques | |||
Parul Kapil | |||
P2860 | cites work | CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity | Q24621645 |
Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts | Q30790246 | ||
The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. | Q33508816 | ||
CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow | Q33968069 | ||
Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. | Q34018474 | ||
Lymphoid chemokines in the CNS. | Q34020894 | ||
Factors supporting intrathecal humoral responses following viral encephalomyelitis. | Q34742821 | ||
B cells and multiple sclerosis | Q34808657 | ||
Control of central nervous system viral persistence by neutralizing antibody | Q34859605 | ||
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system | Q35104199 | ||
Homing of antibody secreting cells | Q35170914 | ||
Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. | Q35176347 | ||
Regulation of plasma-cell development | Q36058417 | ||
Maintenance of serum antibody levels | Q36072426 | ||
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism | Q36228105 | ||
A coordinated change in chemokine responsiveness guides plasma cell movements | Q36369352 | ||
Coronavirus infection of the central nervous system: host-virus stand-off | Q36369843 | ||
Plasma cell ontogeny defined by quantitative changes in blimp-1 expression | Q36399312 | ||
The B cell response in multiple sclerosis | Q36474316 | ||
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies | Q36863593 | ||
Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control | Q37204671 | ||
Organization of immunological memory by bone marrow stroma | Q37692177 | ||
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum | Q37757179 | ||
In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination | Q39939080 | ||
Antibody prevents virus reactivation within the central nervous system | Q41670143 | ||
The role of antibody in recovery from alphavirus encephalitis | Q41672969 | ||
Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. | Q43985466 | ||
Mouse hepatitis virus pathogenesis in the central nervous system is independent of IL-15 and natural killer cells. | Q45419308 | ||
Virus specificity and isotype expression of intraparenchymal antibody-secreting cells during Sindbis virus encephalitis in mice | Q45777848 | ||
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. | Q46023372 | ||
Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis | Q46106385 | ||
CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. | Q46275246 | ||
Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis | Q46423951 | ||
Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis | Q48612585 | ||
Humoral immunity due to long-lived plasma cells. | Q52040025 | ||
Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. | Q52940412 | ||
Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. | Q52956500 | ||
Antibody-mediated clearance of alphavirus infection from neurons | Q68262671 | ||
Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody | Q81404086 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6136-6147 | |
P577 | publication date | 2011-04-20 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis | |
P478 | volume | 85 |
Q47422276 | " The role of CXCR3 in neurological diseases". |
Q40530656 | Activated GL7+ B cells are maintained within the inflamed CNS in the absence of follicle formation during viral encephalomyelitis. |
Q54207057 | Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients. |
Q40204989 | An optimized method for enumerating CNS derived memory B cells during viral-induced inflammation. |
Q36667911 | Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis |
Q30541389 | CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier |
Q36788638 | CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis |
Q38779104 | CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells |
Q52841390 | Characterization of the Antibody Response after Cervical Spinal Cord Injury. |
Q33831703 | Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection |
Q49837687 | Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection |
Q35914296 | Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis |
Q30540694 | Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse |
Q58546206 | Dynamics of Virus-Specific Memory B Cells and Plasmablasts following CNS Viral Infection |
Q34631749 | Early differentiated CD138(high) MHCII+ IgG+ plasma cells express CXCR3 and localize into inflamed kidneys of lupus mice |
Q34225964 | Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. |
Q36913970 | Genome-Wide Transcriptional Profiling Reveals Two Distinct Outcomes in Central Nervous System Infections of Rabies Virus |
Q36919822 | Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection |
Q37228165 | IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis |
Q38272285 | Immune responses to non-tumor antigens in the central nervous system. |
Q37034930 | Increased CXCR3 Expression of Infiltrating Plasma Cells in Hunner Type Interstitial Cystitis. |
Q40527857 | Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis |
Q38084075 | Intrathecal humoral immunity to encephalitic RNA viruses. |
Q35973650 | Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis. |
Q31050845 | Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus |
Q35067939 | Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica |
Q34059107 | Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. |
Q41933450 | Protective Humoral Immunity in the CNS Requires Peripheral CD19-Dependent Germinal Center Formation Following Coronavirus Encephalomyelitis. |
Q36607157 | Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis |
Q35708880 | T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating disease |
Q101351073 | The association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis impact of immunotherapies |
Q36468266 | The chemokine receptor CXCR2 and coronavirus-induced neurologic disease |
Q36054757 | The spleen is the major source of antidonor antibody-secreting cells in murine heart allograft recipients |
Q26829804 | Tissue-resident memory T cells |
Q38202086 | Tracking plasma cell differentiation and survival |
Q57481153 | Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes |
Search more.